Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.0003 |
mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.0003 |
mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0005 |
mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0005 |
mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0005 |
mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |
mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0006 |
mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |